Effect of Coptidis Rhizoma on gastrointestinal system before and after processing with wine based on gut microbiota and short chain fatty acids

BackgroundCoptis deltoidea C.Y. Cheng et Hsiao (CD), commonly used in the treatment of heat-toxin congestion and excessiveness. However, CD needs to be processed with wine for alleviating the bitter and cold of CD, meanwhile, reducing the gastrointestinal damage. The research assessed the discrepant...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Rui Tian (Autor), Wen-Xiao Wang (Autor), Ya-Ya Bai (Autor), Yu-Ping Tang (Autor), Qiao Zhang (Autor), Shi-Jun Yue (Autor)
Format: Książka
Wydane: Frontiers Media S.A., 2024-11-01T00:00:00Z.
Hasła przedmiotowe:
Dostęp online:Connect to this object online.
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_9a5e5bbf7877417db1bf8f46a0a0a458
042 |a dc 
100 1 0 |a Rui Tian  |e author 
700 1 0 |a Wen-Xiao Wang  |e author 
700 1 0 |a Ya-Ya Bai  |e author 
700 1 0 |a Yu-Ping Tang  |e author 
700 1 0 |a Qiao Zhang  |e author 
700 1 0 |a Shi-Jun Yue  |e author 
245 0 0 |a Effect of Coptidis Rhizoma on gastrointestinal system before and after processing with wine based on gut microbiota and short chain fatty acids 
260 |b Frontiers Media S.A.,   |c 2024-11-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2024.1492047 
520 |a BackgroundCoptis deltoidea C.Y. Cheng et Hsiao (CD), commonly used in the treatment of heat-toxin congestion and excessiveness. However, CD needs to be processed with wine for alleviating the bitter and cold of CD, meanwhile, reducing the gastrointestinal damage. The research assessed the discrepant effects of CD on gastrointestinal system before and after processing with wine, and explore the potential mechanisms.MethodsThe ingredients in CD and CD processed with wine (PCD) were performed on Ultra Performance Liquid Chromatography Mass Spectrometry (UPLC-MS). The mice were treated with CD and PCD once a day for 6 weeks (0.65 and 2.6 g/kg, i.g.). The pathological changes of gastrointestinal tract were evaluated, and the serum inflammatory factors and Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-κB) RelA (p65) protein of tissues were determined. The short chain fatty acids (SCFAs) of feces were analyzed by UPLC-MS, the gut microbiota (GM) changes were performed on 16 S rRNA sequencing.ResultsIngredients analysis declared that the alkaloids, flavonoids, phenylpropanoid compounds were the main metabolites in CD and PCD. CD reduced body weight and food intake, and the effect of CD on fecal water content increased first and then decreased with the prolongation of administration time, while its effect on intestinal transport time was exactly the opposite, reduced the SCFAs contents of feces. CD caused different degree of damage to the gastrointestinal tract, and the effect on the small intestine and colon was more obvious, which increased the expression of NF-κB p65 and elevated the inflammatory factors levels. PCD were weaker than that of CD. In addition, CD and PCD can change the composition of GM, and reduced the levels of Lactobacillus, Allobaculum, Ruminococcus, and norank_f_S24-7, increased the levels of Akkermansia, Dorea, Bacteroides, and Blautia at the genus level. However, PCD induced a milder effect of GM dysregulation than that of CD.ConclusionCD can cause damage to the gastrointestinal tract, which may be related to the GM disorders, SCFAs changes-mediated by GM, abnormal NF-κB p65 expression and increased inflammatory factors levels, interestingly, PCD had a lower effect than CD, which may be related to the differences in the types and contents of ingredients in CD after processing. And this study provided data support for the mechanism of processing with wine to alleviate "bitter-cold injury the stomach" of CD. 
546 |a EN 
690 |a Coptis deltoidea 
690 |a wine-processing 
690 |a gut microbiota 
690 |a short chain fatty acids 
690 |a gastrointestinal system 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 15 (2024) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fphar.2024.1492047/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/9a5e5bbf7877417db1bf8f46a0a0a458  |z Connect to this object online.